Asthma and obstructive sleep apnea: Clinical and pathogenic interactions

Journal of Investigative Medicine

Volumn 62, Issue 4, 2014, Pages 665-675

  Puthalapattu, Swathy ^a   Ioachimescu, Octavian C ^b  

^a Topeka Veterans Affairs Medical Center   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Airflow limitation; Airway disease; Asthma; COPD; Endotype; Obstruction; Obstructive sleep apnea; Overlap syndrome; Phenotype; Sleep apnea

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; LEPTIN; VASCULOTROPIN;

ABDOMINAL OBESITY; AIRWAY OBSTRUCTION; AIRWAY PRESSURE; AIRWAY RESISTANCE; AROUSAL; ASTHMA; BODY MASS; BODY WEIGHT; BRONCHOCONSTRICTION; BRONCHOSPASM; BRONCHUS REACTIVITY; COUGHING; DYSPNEA; ESOPHAGUS PRESSURE; EXPIRATORY FLOW; FATIGUE; FOLLOW UP; FUNCTIONAL RESIDUAL CAPACITY; GASTROESOPHAGEAL REFLUX; HUMAN; INCOME; INFLAMMATORY DISEASE; INTERMITTENT HYPOXIA; LUNG VOLUME; NOCTURNAL ASTHMA; NONREM SLEEP; NOSE DISEASE; OXYGENATION; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PERSONALIZED MEDICINE; PHENOTYPE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; REM SLEEP; REVIEW; SLEEP DISORDERED BREATHING; SMOKING; SNORING; SOMNOLENCE; SYSTEMIC DISEASE; WHEEZING; COMORBIDITY; CONGESTIVE HEART FAILURE; DRUG EFFECT; INFLAMMATION; OBESITY; PATHOGENESIS; REFLEX; SLEEP; TREATMENT OUTCOME; COMPLICATION; PATHOLOGY; SLEEP APNEA, OBSTRUCTIVE;

ASTHMA; GASTROESOPHAGEAL REFLUX; HUMANS; OBESITY; SLEEP APNEA, OBSTRUCTIVE;

EID: 84902178445     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0000000000000065     Document Type: Review

References (151)

1. Global Initiative for Asthma: Global strategy for asthmamanagement and prevention. Available at: www.ginasthma.org. Accessed August 2013: National Institutes of Health: National Heart, Lung and Blood Institute, Revised 2008, Updated 2012.
2. USDepartment of Health andHumanServices.National Institutes ofHealth; National Heart, Lung and Blood Institute. National asthma education and prevention: practical guide for the diagnosis and management of asthma. Expert Panel Rep 2. 1997.
3. Agache I, Akdis C, Jutel M, et al. Untangling asthma phenotypes and endotypes. Allergy. 2012;67:835-846.
4. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328: 1230-1235. (Pubitemid 23115702)
5. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013.
6. Ioachimescu OC, Teodorescu M. Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome. Respirology. 2013;18:421-431.
7. Kasasbeh A, Kasasbeh E, Krishnaswamy G. Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complexVa hypothetical review. Sleep Med Rev. 2007;11:47-58. (Pubitemid 46110872)
8. Alkhalil M, Schulman E, Getsy J. Obstructive sleep apnea syndrome and asthma: what are the links? J Clin Sleep Med. 2009;5:71-78.
9. Yigla M, Tov N, Solomonov A, et al. Difficult-to-control asthma and obstructive sleep apnea. J Asthma. 2003;40:865-871. (Pubitemid 38057666)
10. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26: 812-818. (Pubitemid 41632037)
11. Teodorescu M, Consens FB, Bria WF, et al. Correlates of daytime sleepiness in patients with asthma. Sleep Med. 2006;7:607-613. (Pubitemid 44804237)
12. Auckley D, Moallem M, Shaman Z, et al. Findings of a Berlin Questionnaire survey: comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med. 2008;9:494-499. (Pubitemid 351837467)
13. Teodorescu M, Polomis DA, Hall SV, et al. Association of obstructive sleep apnea risk with asthma control in adults. Chest. 2010;138: 543-550.
14. Knuiman M, James A, Divitini M, et al. Longitudinal study of risk factors for habitual snoring in a general adult population: the Busselton Health Study. Chest. 2006;130:1779-1783. (Pubitemid 46033433)
15. Teodorescu M, Barnet J, Young T, et al. Asthma predicts 8 year incidence of obstructive sleep apnea in the wisconsin sleep cohort. Availabale at: http://www.atsjournals.org/doi/book/10.1164/ajrccm-conference.2013.A110. Am J Respir Crit Care Med 2013; 187.
16. Julien JY, Martin JG, Ernst P, et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009;124:371-376.
17. Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006;27: 495-503. (Pubitemid 43372522)
18. Sutherland ER, Camargo CA Jr, Busse WW, et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy Asthma Proc. 2010;31:20-25.
19. Rodrigo GJ, Plaza V. Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study. Chest. 2007;132:1513-1519. (Pubitemid 350156007)
20. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218-224.
21. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315-323.
22. Borrell LN, Nguyen EA, Roth LA, et al. Childhood obesity and asthma control in the GALA II and SAGE II studies. Am J Respir Crit Care Med. 2013;187:697-702.
23. Fitzpatrick MF, Martin K, Fossey E, et al. Snoring, asthma and sleep disturbance in Britain: a community-based survey. Eur Respir J. 1993;6:531-535. (Pubitemid 23135191)
24. Janson C, De BackerW, Gislason T, et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J. 1996;9:2132-2138. (Pubitemid 26333556)
25. Kalra M, Biagini J, Bernstein D, et al. Effect of asthma on the risk of obstructive sleep apnea syndrome in atopic women. Ann Allergy Asthma Immunol. 2006;97:231-235. (Pubitemid 44272592)
26. Ekici A, Ekici M, Kurtipek E, et al. Association of asthma-related symptoms with snoring and apnea and effect on health-related quality of life. Chest. 2005;128:3358-3363. (Pubitemid 41698663)
27. Teodorescu M, Polomis DA, Teodorescu MC, et al. Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults. J Asthma. 2012;49:620-628.
28. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis. 1988;137: 1502-1504.
29. Bunch TJ, Packer DL, Jahangir A, et al. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol. 2008;102:1207-1211.
30. Guilleminault C, Quera-Salva MA, Powell N, et al. Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J. 1988;1: 902-907. (Pubitemid 19015301)
31. Ciftci TU, Ciftci B, Guven SF, et al. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med. 2005;99:529-534. (Pubitemid 40468498)
32. Lafond C, Sériès F, Lemière C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J. 2007;29:307-311.
33. Alharbi M, Almutairi A, Alotaibi D, et al. The prevalence of asthma in patients with obstructive sleep apnoea. Prim Care Respir J. 2009;18: 328-330.
34. Layon J, Banner MJ, Jaeger MJ, et al. Continuous positive airway pressure and expiratory positive airway pressure increase functional residual capacity equivalently. Chest. 1986;89:517-521. (Pubitemid 16133712)
35. Campana LM, Malhotra A, Suki B, et al. The effect of lung stretch during sleep on airway mechanics in overweight and obese asthma. Respir Physiol Neurobiol. 2013;185:304-312.
36. Leiter JC, Knuth SL, Bartlett D Jr. The effect of sleep deprivation on activity of the genioglossus muscle. Am Rev Respir Dis. 1985;132: 1242-1245. (Pubitemid 16156380)
37. Sériès F, Roy N, Marc I. Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med. 1994;150:481-485.
38. Ballard RD, Irvin CG, Martin RJ, et al. Influence of sleep on lung volume in asthmatic patients and normal subjects. J Appl Physiol (1985). 1990;68:2034-2041.
39. Shapiro CM, Catterall JR, Montgomery I, et al. Do asthmatics suffer bronchoconstriction during rapid eye movement sleep? Br Med J (Clin Res Ed). 1986;292:1161-1164.
40. Morgan AD, Rhind GB, Connaughton JJ, et al. Breathing patterns during sleep in patients with nocturnal asthma. Thorax. 1987;42: 600-603. (Pubitemid 17118731)
41. Bellia V, Cuttitta G, Insalaco G, et al. Relationship of nocturnal bronchoconstriction to sleep stages. Am Rev Respir Dis. 1989;140: 363-367. (Pubitemid 19218350)
42. Perez GF, Gutierrez MJ, Huseni S, et al. Oximetry signal processing identifies REM sleep-related vulnerability trait in asthmatic children. Sleep Disord. 2013;2013:406157.
43. van de Graaff WB. Thoracic influence on upper airway patency. J Appl Physiol (1985). 1988;65:2124-2131.
44. Morrell MJ, Badr MS. Effects of NREM sleep on dynamic within-breath changes in upper airway patency in humans. J Appl Physiol (1985). 1998;84:190-199.
45. Tamisier R, Pepin JL, Wuyam B, et al. Expiratory changes in pressure: flow ratio during sleep in patients with sleep-disordered breathing. Sleep. 2004;27:240-248. (Pubitemid 44138832)
46. Bjermer L. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. J Allergy Clin Immunol. 2007;120:1269-1275. (Pubitemid 350216606)
47. Reid MB, Lännergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med. 2002;166:479-484.
48. Shipley JE, Schteingart DE, Tandon R, et al. Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep. 1992;15: 514-518.
49. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med. 2002;165:1377-1383. (Pubitemid 34522940)
50. Williams AJ, Baghat MS, Stableforth DE, et al. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 1983;38:813-821. (Pubitemid 14209462)
51. Kakkar RK, Berry RB. Asthma and obstructive sleep apnea: at different ends of the same airway? Chest. 2009;135:1115-1116.
52. Gleeson K, Zwillich CW, Braier K, et al. Breathing route during sleep. Am Rev Respir Dis. 1986;134:115-120. (Pubitemid 16057470)
53. Teculescu D, Mayeux L, Montaut-Verient B, et al. An epidemiologic study of sleep-disordered breathing in the male population of Lorraine: preliminary results. Sante Publique. 1998;10:177-190. (Pubitemid 28396789)
54. Nayak AS. The asthma and allergic rhinitis link. Allergy Asthma Proc. 2003;24:395-402.
55. Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161:1514-1519. (Pubitemid 32679564)
56. Teodorescu M, Consens FB, Bria WF, et al. Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma. Chest. 2009;135:1125-1132.
57. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63(Suppl 86):8-160.
58. Thorstensen WM, Sue-Chu M, Bugten V, et al. Nasal flow, volumes, and minimal cross sectional areas in asthmatics. Respir Med. 2013;107: 1515-1520.
59. Piessens P, Hens G, Lemkens N, et al. Effect of adenotonsillectomy on the use of respiratory medication. Int J Pediatr Otorhinolaryngol. 2012;76:906-910.
60. Lin DC, Chandra RK, Tan BK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25:205-208.
61. Wenzel SE, Szefler SJ, Leung DY, et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156:737-743. (Pubitemid 27396409)
62. Wenzel S. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy. 2012;42:650-658.
63. Thomson NC, Chaudhuri R, Heaney LG, et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol. 2013;131:1008-1016.
64. Bijaoui EL, Champagne V, Baconnier PF, et al. Mechanical properties of the lung and upper airways in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2002;165:1055-1061. (Pubitemid 34415810)
65. Ballard RD. Sleep, respiratory physiology, and nocturnal asthma. Chronobiol Int. 1999;16:565-580. (Pubitemid 29463829)
66. Plowman L, Edwards PH, Lauff DC, et al. Tracheal smooth muscle responses to upper airway pressure in conscious dogs. J Appl Physiol (1985). 1990;68:1555-1561.
67. Nakayama K. Surgical removal of the carotid body for bronchial asthma. Dis Chest. 1961;40:595-604.
68. Montesi SB, Bajwa EK, Malhotra A. Biomarkers of sleep apnea. Chest. 2012;142:239-245.
69. Lavie L. Obstructive sleep apnoea syndromeVan oxidative stress disorder. Sleep Med Rev. 2003;7:35-51. (Pubitemid 36188305)
70. Carpagnano GE, Kharitonov SA, Resta O, et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002;122:1162-1167. (Pubitemid 35339525)
71. Carpagnano GE, Kharitonov SA, Resta O, et al. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003;124:1386-1392. (Pubitemid 37290049)
72. Li AM, Hung E, Tsang T, et al. Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnoea. Thorax. 2007;62:75-79. (Pubitemid 46101769)
73. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007;119:1043-1052; quiz 1053-1044.
74. Huang TJ, Haddad EB, Fox AJ, et al. Contribution of bradykinin B(1) and B(2) receptors in allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med. 1999;160:1717-1723.
75. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789-815. (Pubitemid 38680442)
76. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2006;174:824-830. (Pubitemid 44511665)
77. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004;89:2119-2126. (Pubitemid 38619840)
78. Mullington JM, Haack M, Toth M, et al. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis. 2009;51:294-302.
79. Patel SR, Zhu X, Storfer-Isser A, et al. Sleep duration and biomarkers of inflammation. Sleep. 2009;32:200-204.
80. Alam I, Lewis K, Stephens JW, et al. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev. 2007;8:119-127. (Pubitemid 46239440)
81. Sariman N, Levent E, Cubuk R, et al. Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients. Sleep Breath. 2011;15:341-350.
82. Mehra R, Redline S. Sleep apnea: a proinflammatory disorder that coaggregates with obesity. J Allergy Clin Immunol. 2008;121: 1096-1102. (Pubitemid 351626934)
83. Mehra R, Storfer-Isser A, Kirchner HL, et al. Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med. 2006;166:1725-1731. (Pubitemid 44414460)
84. Ciftci TU, Kokturk O, Bukan N, et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004;28:87-91. (Pubitemid 39302489)
85. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001;107:295-301. (Pubitemid 32173907)
86. Simcock DE, Kanabar V, Clarke GW, et al. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med. 2007;176:146-153. (Pubitemid 47057850)
87. Asai K, Kanazawa H, Kamoi H, et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33:595-599. (Pubitemid 36629683)
88. Imagawa S, Yamaguchi Y, Higuchi M, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apneaVhypopnea syndrome. Blood. 2001;98:1255-1257.
89. Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med. 2002;165:67-70. (Pubitemid 34053359)
90. Kuroki M, Voest EE, Amano S, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 1996;98:1667-1675. (Pubitemid 26327878)
91. Sideleva O, Suratt BT, Black KE, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186:598-605.
92. Shore SA, Schwartzman IN, Mellema MS, et al. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol. 2005;115: 103-109. (Pubitemid 40075428)
93. Guler N, Kirerleri E, Ones U, et al. Leptin: does it have any role in childhood asthmä J Allergy Clin Immunol. 2004;114:254-259.
94. Holguin F, Rojas M, Brown LA, et al. Airway and plasma leptin and adiponectin in lean and obese asthmatics and controls. J Asthma. 2011;48:217-223.
95. Lugogo NL, Hollingsworth JW, Howell DL, et al. Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med. 2012;186:404-411.
96. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000;279:H234-H237. (Pubitemid 30616665)
97. Tatsumi K, Kasahara Y, Kurosu K, et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127:716-721. (Pubitemid 40775497)
98. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004;169:361-366. (Pubitemid 38134815)
99. Snashall PD, Chung KF. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. Am Rev Respir Dis. 1991;144:945-956.
100. Borst MM, Beuthien W, Schwencke C, et al. Desensitization of the pulmonary adenylyl cyclase system: a cause of airway hyperresponsiveness in congestive heart failure? J Am Coll Cardiol. 1999;34:848-856.
101. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
102. Taylor DR, Fergusson DM, Milne BJ, et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction. 2002;97:1055-1061.
103. Stein RT, Holberg CJ, Sherrill D, et al. Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children's Respiratory Study. Am J Epidemiol. 1999;149:1030-1037. (Pubitemid 29246868)
104. Dezateux C, Stocks J, Dundas I, et al. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med. 1999;159: 403-410. (Pubitemid 29084858)
105. Chen CH, Xirasagar S, Lin HC. Seasonality in adult asthma admissions, air pollutant levels, and climate: a population-based study. J Asthma. 2006;43:287-292.
106. Basner M, Griefahn B, Berg Mv. Aircraft noise effects on sleep: mechanisms, mitigation and research needs. Noise Health. 2010;12: 95-109.
107. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol. 2008;121:1087-1093, quiz 1094-1085.
108. Brumpton B, Langhammer A, Romundstad P, et al. General and abdominal obesity and incident asthma in adults: the HUNT study. Eur Respir J. 2013;41:323-329.
109. Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol (1985). 2010;108:735-743.
110. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol. 2005;115:897-909, quiz 910.
111. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175:661-666. (Pubitemid 46536480)
112. Dixon AE, Holguin F, Sood A, et al. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc. 2010;7:325-335.
113. Camargo CA Jr, Weiss ST, Zhang S, et al. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med. 1999;159:2582-2588.
114. Guerra S,Wright AL, Morgan WJ, et al. Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am J Respir Crit Care Med. 2004;170:78-85. (Pubitemid 38997755)
115. Lugogo NL, Kraft M, Dixon AE. Does obesity produce a distinct asthma phenotype? J Appl Physiol (1985). 2010;108:729-734.
116. Stenius-Aarniala B, Poussa T, Kvarnstro?m J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ. 2000;320:827-832. (Pubitemid 30175861)
117. Maniscalco M, Zedda A, Faraone S, et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med. 2008;102: 102-108. (Pubitemid 350151825)
118. Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128:508-515; e501-e502.
119. Ma J, Xiao L. Association of general and central obesity and atopic and nonatopic asthma in US adults. J Asthma. 2013;50:395-402.
120. Dixon AE, Shade DM, Cohen RI, et al. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma. 2006;43: 553-558. (Pubitemid 44567610)
121. Sismanopoulos N, Delivanis DA, Mavrommati D, et al. Do mast cells link obesity and asthma? Allergy. 2013;68:8-15.
122. Ali Z, Ulrik CS. Obesity and asthma: a coincidence or a causal relationship? A systematic review. Respir Med. 2013;107:1287-1300.
123. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716-725.
124. Demeter P, Pap A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. J Gastroenterol. 2004;39: 815-820. (Pubitemid 39409660)
125. Harding SM. Gastroesophageal reflux: a potential asthma trigger. Immunol Allergy Clin North Am. 2005;25:131-148. (Pubitemid 39576681)
126. Green BT, Broughton WA, O'Connor JB. Marked improvement in nocturnal gastroesophageal reflux in a large cohort of patients with obstructive sleep apnea treated with continuous positive airway pressure. Arch Intern Med. 2003;163:41-45. (Pubitemid 36091599)
127. Valipour A, Makker HK, Hardy R, et al. Symptomatic gastroesophageal reflux in subjects with a breathing sleep disorder. Chest. 2002;121: 1748-1753. (Pubitemid 34634391)
128. Kerr P, Shoenut JP, Steens RD, et al. Nasal continuous positive airway pressure. A new treatment for nocturnal gastroesophageal reflux? J Clin Gastroenterol. 1993;17:276-280. (Pubitemid 23360377)
129. Shepherd KL, James AL, Musk AW, et al. Gastro-oesophageal reflux symptoms are related to the presence and severity of obstructive sleep apnoea. J Sleep Res. 2011;20:241-249.
130. Kerr P, Shoenut JP, Millar T, et al. Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome. Chest. 1992;101:1539-1544.
131. Ing AJ, Ngu MC, Breslin AB. Obstructive sleep apnea and gastroesophageal reflux. Am J Med. 2000;108(Suppl 4a):120S-125S.
132. Martin ME, Grunstein MM, Larsen GL. The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann Allergy. 1982;49:318-322. (Pubitemid 13204181)
133. Jack CI, Calverley PM, Donnelly RJ, et al. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax. 1995;50:201-204.
134. Berg S, Hoffstein V, Gislason T. Acidification of distal esophagus and sleep-related breathing disturbances. Chest. 2004;125:2101-2106. (Pubitemid 38788176)
135. Kuribayashi S, Kusano M, Kawamura O, et al. Mechanism of gastroesophageal reflux in patients with obstructive sleep apnea syndrome. Neurogastroenterol Motil. 2010;22:e611-e172.
136. Kuribayashi S, Massey BT, Hafeezullah M, et al. Upper esophageal sphincter and gastroesophageal junction pressure changes act to prevent gastroesophageal and esophagopharyngeal reflux during apneic episodes in patients with obstructive sleep apnea. Chest. 2010;137:769-776.
137. Shepherd K, Hillman D, Holloway R, et al. Mechanisms of nocturnal gastroesophageal reflux events in obstructive sleep apnea. Sleep Breath. 2011;15:561-570.
138. EmilssonO? I, BengtssonA, FranklinKA, et al.Nocturnal gastro-oesophageal reflux, asthma and symptoms of OSA: a longitudinal, general population study. Eur Respir J. 2013;41:1347-1354.
139. Ioachimescu OC, Collop NA. Sleep-disordered breathing. Neurol Clin. 2012;30:1095-1136.
140. Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J. 1995;8:306-313.
141. Dubois AB, Botelho SY, Comroe JH Jr. A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956;35:327-335.
142. Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22:1026-1041. (Pubitemid 37540659)
143. Paredi P, Goldman M, Alamen A, et al. Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease. Thorax. 2010;65:263-267.
144. Barach A, Swenson P. Effect of breathing gases under positive pressure on lumens of small and medium-sized bronchi. Arch Intern Med. 1939;63:3.
145. Shivaram U, Donath J, Khan FA, et al. Effects of continuous positive airway pressure in acute asthma. Respiration. 1987;52:157-162. (Pubitemid 18009107)
146. Shivaram U, Miro AM, Cash ME, et al. Cardiopulmonary responses to continuous positive airway pressure in acute asthma. J Crit Care. 1993;8:87-92. (Pubitemid 23209394)
147. Wysocki M, Antonelli M. Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure. Eur Respir J. 2001;18:209-220. (Pubitemid 32717450)
148. Martin JG, Shore SA, Engel LA. Mechanical load and inspiratory muscle action during induced asthma. Am Rev Respir Dis. 1983;128:455-460. (Pubitemid 13006145)
149. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129-1134. (Pubitemid 36297204)
150. Sanner BM, Kollhosser P, Buechner N, et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J. 2004;23:601-604. (Pubitemid 38456004)
151. Harsch IA, Schahin SP, Radespiel-Tro?ger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. AmJ Respir Crit Care Med. 2004;169:156-162. (Pubitemid 38114528)